SPX4,280.15+72.88 1.73%
DIA337.83+4.12 1.23%
IXIC13,047.19+267.27 2.09%

--Morgan Stanley Lowers CME Group's Price Target to $226 From $242, Keeps Equalweight Rating

--Morgan Stanley Lowers CME Group's Price Target to $226 From $242, Keeps Equalweight Rating

MT Newswires · 07/28/2022 07:22

Please log in to view news